Laboratorios Farmaceuticos Rovi(ES:ROVI)
€69.20-0.95 (-1.35%)
ES:ROVI
Laboratorios Farmaceuticos Rovi financials statements
€69.20
At close:-0.95 (-1.35%)
Want to see ES:ROVI full AI Analyst Report?
Laboratorios Farmaceuticos Rovi (ROVI) Income Statement
46 Followers
Laboratorios Farmaceuticos Rovi Income Statement
Last quarter (Q3 2026), Laboratorios Farmaceuticos Rovi's total revenue was €266.01M, an increase of 26.39% from the same quarter last year. In Q3, Laboratorios Farmaceuticos Rovi's net income was €78.42M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 743.48M | € 763.75M | € 829.51M | € 817.70M | € 648.68M | |
| € 451.65M | € 478.35M | € 483.34M | € 519.61M | € 384.82M | |
| € 278.51M | € 298.80M | € 263.09M | € 263.76M | € 203.34M | |
| Depreciation and Amortization | € 30.37M | € 28.02M | € 24.33M | € 22.87M | € 21.36M |
| € 203.52M | € 207.69M | € 245.81M | € 281.49M | € 204.72M | |
| € 173.14M | € 179.54M | € 220.25M | € 255.85M | € 181.57M | |
| € 10.12M | € -1.85M | € 154.00K | € 1.92M | € 1.24M | |
| € 183.26M | € 177.69M | € 220.41M | € 257.97M | € 182.63M | |
| € 140.44M | € 136.88M | € 170.34M | € 199.67M | € 153.08M | |
| Per Share Metrics | |||||
| Basic EPS | € 2.75 | € 2.67 | € 3.29 | € 3.73 | € 2.76 |
| Diluted EPS | € 2.75 | € 2.67 | € 3.29 | € 3.73 | € 2.76 |
| Weighted Average Shares Outstanding | 51.15M | 51.27M | 51.82M | 53.47M | 55.40M |
| Weighted Average Shares Outstanding (Diluted) | 51.15M | 51.27M | 51.82M | 53.47M | 55.40M |
Currency in EUR

